7-[1-(2,2-difluoro-3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-ethylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-[ethyl(methyl)amino]propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-methyl-3-(6-methyl-3-pyridinyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyrimidin-5-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine

C136H143F2N47O — CID 159943380

IUPAC7-[1-(2,2-difluoro-3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-ethylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-[ethyl(methyl)amino]propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-methyl-3-(6-methyl-3-pyridinyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyrimidin-5-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine
SMILESCC(C)c1cnnc(Nc2ccc3ncc(-c4cnn(CC(F)(F)CN5CCOCC5)c4)cc3n2)c1.CC(C)c1cnnc(Nc2ccc3ncc(-c4cnn(Cc5cncnc5)c4)cc3n2)c1.CCN(C)CCCn1cc(-c2cnc3ccc(Nc4cc(C(C)C)cnn4)nc3c2)cn1.CCc1cnnc(Nc2ccc3ncc(-c4cn(C)nc4C)cc3n2)c1.Cc1ccc(-c2nn(C)cc2-c2cnc3ccc(Nc4cc(C(C)C)cnn4)nc3c2)cn1.Cc1nn(C)cc1-c1cnc2ccc(Nc3cc(C(C)C)cnn3)nc2c1
InChIInChI=1S/C25H28F2N8O.C25H24N8.C24H30N8.C23H21N9.C20H21N7.C19H19N7/c1-17(2)18-10-24(33-29-12-18)32-23-4-3-21-22(31-23)9-19(11-28-21)20-13-30-35(14-20)16-25(26,27)15-34-5-7-36-8-6-34;1-15(2)18-10-24(31-28-13-18)30-23-8-7-21-22(29-23)9-19(12-27-21)20-14-33(4)32-25(20)17-6-5-16(3)26-11-17;1-5-31(4)9-6-10-32-16-20(15-27-32)19-11-22-21(25-13-19)7-8-23(28-22)29-24-12-18(17(2)3)14-26-30-24;1-15(2)17-6-23(31-27-10-17)30-22-4-3-20-21(29-22)5-18(9-26-20)19-11-28-32(13-19)12-16-7-24-14-25-8-16;1-12(2)14-8-20(25-22-10-14)24-19-6-5-17-18(23-19)7-15(9-21-17)16-11-27(4)26-13(16)3;1-4-13-7-19(24-21-9-13)23-18-6-5-16-17(22-18)8-14(10-20-16)15-11-26(3)25-12(15)2/h3-4,9-14,17H,5-8,15-16H2,1-2H3,(H,31,32,33);5-15H,1-4H3,(H,29,30,31);7-8,11-17H,5-6,9-10H2,1-4H3,(H,28,29,30);3-11,13-15H,12H2,1-2H3,(H,29,30,31);5-12H,1-4H3,(H,23,24,25);5-11H,4H2,1-3H3,(H,22,23,24)
InChIKeyOBEDTAMUCBVXNY-UHFFFAOYSA-N
MW2489.96 g/mol
LogP25.09
Rot. Bonds36

About 7-[1-(2,2-difluoro-3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-ethylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-[ethyl(methyl)amino]propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-methyl-3-(6-methyl-3-pyridinyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyrimidin-5-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine

7-[1-(2,2-difluoro-3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-ethylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-[ethyl(methyl)amino]propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-methyl-3-(6-methyl-3-pyridinyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyrimidin-5-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine (PubChem CID 159943380) has the molecular formula C136H143F2N47O and a molecular weight of 2489.96 g/mol. Its IUPAC name is 7-[1-(2,2-difluoro-3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-ethylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-[ethyl(methyl)amino]propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-methyl-3-(6-methyl-3-pyridinyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyrimidin-5-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine.

Molecular Properties

Compound Name7-[1-(2,2-difluoro-3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-ethylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-[ethyl(methyl)amino]propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-methyl-3-(6-methyl-3-pyridinyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyrimidin-5-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine
PubChem CID159943380
Molecular FormulaC136H143F2N47O
Molecular Weight2489.96 g/mol
Exact Mass2488.26
IUPAC Name7-[1-(2,2-difluoro-3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-ethylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-[ethyl(methyl)amino]propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-methyl-3-(6-methyl-3-pyridinyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyrimidin-5-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine
SMILESCC(C)c1cnnc(Nc2ccc3ncc(-c4cnn(CC(F)(F)CN5CCOCC5)c4)cc3n2)c1.CC(C)c1cnnc(Nc2ccc3ncc(-c4cnn(Cc5cncnc5)c4)cc3n2)c1.CCN(C)CCCn1cc(-c2cnc3ccc(Nc4cc(C(C)C)cnn4)nc3c2)cn1.CCc1cnnc(Nc2ccc3ncc(-c4cn(C)nc4C)cc3n2)c1.Cc1ccc(-c2nn(C)cc2-c2cnc3ccc(Nc4cc(C(C)C)cnn4)nc3c2)cn1.Cc1nn(C)cc1-c1cnc2ccc(Nc3cc(C(C)C)cnn3)nc2c1
InChIInChI=1S/C25H28F2N8O.C25H24N8.C24H30N8.C23H21N9.C20H21N7.C19H19N7/c1-17(2)18-10-24(33-29-12-18)32-23-4-3-21-22(31-23)9-19(11-28-21)20-13-30-35(14-20)16-25(26,27)15-34-5-7-36-8-6-34;1-15(2)18-10-24(31-28-13-18)30-23-8-7-21-22(29-23)9-19(12-27-21)20-14-33(4)32-25(20)17-6-5-16(3)26-11-17;1-5-31(4)9-6-10-32-16-20(15-27-32)19-11-22-21(25-13-19)7-8-23(28-22)29-24-12-18(17(2)3)14-26-30-24;1-15(2)17-6-23(31-27-10-17)30-22-4-3-20-21(29-22)5-18(9-26-20)19-11-28-32(13-19)12-16-7-24-14-25-8-16;1-12(2)14-8-20(25-22-10-14)24-19-6-5-17-18(23-19)7-15(9-21-17)16-11-27(4)26-13(16)3;1-4-13-7-19(24-21-9-13)23-18-6-5-16-17(22-18)8-14(10-20-16)15-11-26(3)25-12(15)2/h3-4,9-14,17H,5-8,15-16H2,1-2H3,(H,31,32,33);5-15H,1-4H3,(H,29,30,31);7-8,11-17H,5-6,9-10H2,1-4H3,(H,28,29,30);3-11,13-15H,12H2,1-2H3,(H,29,30,31);5-12H,1-4H3,(H,23,24,25);5-11H,4H2,1-3H3,(H,22,23,24)
InChIKeyOBEDTAMUCBVXNY-UHFFFAOYSA-N
XLogP25.09
TPSA542.84 Ų
H-Bond Donors6
H-Bond Acceptors48
Rotatable Bonds36
Heavy Atoms186
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002489.96
LogP ≤ 525.09
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1048

Analyze 7-[1-(2,2-difluoro-3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-ethylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-[ethyl(methyl)amino]propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-methyl-3-(6-methyl-3-pyridinyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyrimidin-5-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-[3-(6-piperazin-1-yl-3-pyridinyl)-2-[(E)-2-quinolin-2-ylethenyl]imidazo[1,2-b]pyridazin-8-yl]morpholine
CID 117728539
4-[3-(6-Piperazin-1-yl-3-pyridinyl)-2-(2-quinolin-2-ylethyl)imidazo[1,2-b]pyridazin-8-yl]morpholine
CID 117728565
US10829493, Example 14
CID 155190305
US10829493, Example 15
CID 155190322
6-(6-morpholin-4-yl-3-pyridinyl)-N-pyridin-4-ylpyrrolo[2,1-f][1,2,4]triazin-4-amine
CID 118711891
4-[3-(6-Piperazin-1-yl-3-pyridinyl)-2-(quinolin-2-ylmethyl)imidazo[1,2-b]pyridazin-8-yl]morpholine
CID 155545902
N-[[8-morpholin-4-yl-3-(6-piperazin-1-yl-3-pyridinyl)imidazo[1,2-b]pyridazin-2-yl]methyl]quinolin-2-amine
CID 86582300
8-morpholin-4-yl-3-(6-piperazin-1-yl-3-pyridinyl)-N-(quinolin-2-ylmethyl)imidazo[1,2-b]pyridazin-2-amine
CID 86582453
7-[2-[5-[4-amino-5-(1-methylpyrazol-3-yl)pyrrolo[2,3-d]pyrimidin-7-yl]-3-pyridinyl]ethyl]-2-ethyl-N-(2-methoxyethyl)-1,5-naphthyridin-4-amine
CID 156304030
5-[3-(2,2-difluoroethyl)-2-methylimidazo[4,5-b]pyridin-5-yl]-N-[4-(morpholin-4-ylmethyl)cyclohexyl]pyrrolo[2,1-f][1,2,4]triazin-2-amine
CID 168219243
(2S)-2-[[4-[4-[4-(5-benzylpyrimidin-2-yl)piperazin-1-yl]pyrrolo[2,1-f][1,2,4]triazin-6-yl]pyrazol-1-yl]methyl]morpholine
CID 118032959
6-[4-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]phenyl]-N-pyridin-4-ylpyrrolo[2,1-f][1,2,4]triazin-4-amine
CID 118711892

Frequently Asked Questions

What is the IUPAC name of 7-[1-(2,2-difluoro-3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-ethylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-[ethyl(methyl)amino]propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-methyl-3-(6-methyl-3-pyridinyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyrimidin-5-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine?
The IUPAC name of 7-[1-(2,2-difluoro-3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-ethylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-[ethyl(methyl)amino]propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-methyl-3-(6-methyl-3-pyridinyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyrimidin-5-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine (CID 159943380) is 7-[1-(2,2-difluoro-3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-ethylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-[ethyl(methyl)amino]propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-methyl-3-(6-methyl-3-pyridinyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyrimidin-5-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine.
What is the SMILES notation for 7-[1-(2,2-difluoro-3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-ethylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-[ethyl(methyl)amino]propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-methyl-3-(6-methyl-3-pyridinyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyrimidin-5-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine?
The canonical SMILES for 7-[1-(2,2-difluoro-3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-ethylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-[ethyl(methyl)amino]propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-methyl-3-(6-methyl-3-pyridinyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyrimidin-5-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine is CC(C)c1cnnc(Nc2ccc3ncc(-c4cnn(CC(F)(F)CN5CCOCC5)c4)cc3n2)c1.CC(C)c1cnnc(Nc2ccc3ncc(-c4cnn(Cc5cncnc5)c4)cc3n2)c1.CCN(C)CCCn1cc(-c2cnc3ccc(Nc4cc(C(C)C)cnn4)nc3c2)cn1.CCc1cnnc(Nc2ccc3ncc(-c4cn(C)nc4C)cc3n2)c1.Cc1ccc(-c2nn(C)cc2-c2cnc3ccc(Nc4cc(C(C)C)cnn4)nc3c2)cn1.Cc1nn(C)cc1-c1cnc2ccc(Nc3cc(C(C)C)cnn3)nc2c1.
What is the InChIKey of 7-[1-(2,2-difluoro-3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-ethylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-[ethyl(methyl)amino]propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-methyl-3-(6-methyl-3-pyridinyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyrimidin-5-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine?
The InChIKey is OBEDTAMUCBVXNY-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H28F2N8O.C25H24N8.C24H30N8.C23H21N9.C20H21N7.C19H19N7/c1-17(2)18-10-24(33-29-12-18)32-23-4-3-21-22(31-23)9-19(11-28-21)20-13-30-35(14-20)16-25(26,27)15-34-5-7-36-8-6-34;1-15(2)18-10-24(31-28-13-18)30-23-8-7-21-22(29-23)9-19(12-27-21)20-14-33(4)32-25(20)17-6-5-16(3)26-11-17;1-5-31(4)9-6-10-32-16-20(15-27-32)19-11-22-21(25-13-19)7-8-23(28-22)29-24-12-18(17(2)3)14-26-30-24;1-15(2)17-6-23(31-27-10-17)30-22-4-3-20-21(29-22)5-18(9-26-20)19-11-28-32(13-19)12-16-7-24-14-25-8-16;1-12(2)14-8-20(25-22-10-14)24-19-6-5-17-18(23-19)7-15(9-21-17)16-11-27(4)26-13(16)3;1-4-13-7-19(24-21-9-13)23-18-6-5-16-17(22-18)8-14(10-20-16)15-11-26(3)25-12(15)2/h3-4,9-14,17H,5-8,15-16H2,1-2H3,(H,31,32,33);5-15H,1-4H3,(H,29,30,31);7-8,11-17H,5-6,9-10H2,1-4H3,(H,28,29,30);3-11,13-15H,12H2,1-2H3,(H,29,30,31);5-12H,1-4H3,(H,23,24,25);5-11H,4H2,1-3H3,(H,22,23,24).
What are the key properties of 7-[1-(2,2-difluoro-3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-ethylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-[ethyl(methyl)amino]propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-methyl-3-(6-methyl-3-pyridinyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyrimidin-5-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine?
7-[1-(2,2-difluoro-3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-ethylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-[ethyl(methyl)amino]propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-methyl-3-(6-methyl-3-pyridinyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyrimidin-5-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine has a molecular weight of 2489.96 g/mol, XLogP of 25.09, 36 rotatable bonds, 6 hydrogen bond donors, and 48 hydrogen bond acceptors.
Where does this data come from?
All data for 7-[1-(2,2-difluoro-3-morpholin-4-ylpropyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-ethylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-(1,3-dimethylpyrazol-4-yl)-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-[3-[ethyl(methyl)amino]propyl]pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;7-[1-methyl-3-(6-methyl-3-pyridinyl)pyrazol-4-yl]-N-(5-propan-2-ylpyridazin-3-yl)-1,5-naphthyridin-2-amine;N-(5-propan-2-ylpyridazin-3-yl)-7-[1-(pyrimidin-5-ylmethyl)pyrazol-4-yl]-1,5-naphthyridin-2-amine is sourced from PubChem (CID 159943380), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).